Advanced breast cancer has increased slightly among young women, a 34-year analysis suggests. The disease is still uncommon among women younger than 40, and the small change has experts scratching their heads about possible reasons.
1
Not all patient drug trials published in even the most prestigious of medical journals can be taken as gospel, say researchers, who have found a high proportion of "spin and bias" in the reporting of results.
Breast cancer survivors over the age of 55 are at greater risk for developing diabetes than women who have never had breast cancer, a new Canadian study has found.
The breast cancer drug tamoxifen further reduces the risk of disease recurrence and death when the treatment period is doubled to 10 years from the current standard of five, a new study suggests.
Health Canada is warning Canadians and their health-care providers that thermography machines are not approved for use in Canada for breast cancer screening.
Women who work in certain manufacturing environments face an increased risk of breast cancer of nearly 50 per cent due to years of exposure to carcinogens and hormone-disrupting chemicals, a new landmark Canadian study shows.
An independent panel in Britain has found that for every life saved, roughly three other women were overdiagnosed, meaning they were unnecessarily treated for a cancer that would never have threatened their lives.
Dr. Ann Chambers, Canada's research chair in oncology and a professor of oncology at the University of Western Ontario, says there are still many myths and misconceptions about breast cancer.
An experimental breast cancer treatment that directly targets disease cells appears to shrink tumours and improve survival rates, a new study says, and could one day lead to more effective treatment of other types of cancer with fewer side effects.
